Priya Sachdeva

Stock Analyst at UBS

(0.45)

# 3,978

Out of 4,859 analysts

4

Total ratings

n/a

Success rate

-9.09%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$320 → $330	$253.40	+30.23%	3	Apr 24, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$11.23	+51.38%	1	Jan 21, 2025

Penumbra

Apr 24, 2025

Maintains: Buy

Price Target: $320 → $330

Current: $253.40

Upside: +30.23%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $11.23

Upside: +51.38%